CStone Pharmaceuticals (STU:PH4) Short-Term Capital Lease Obligation : €0.00 Mil (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals Short-Term Capital Lease Obligation?

CStone Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was €0.00 Mil.

CStone Pharmaceuticals's quarterly Short-Term Capital Lease Obligation declined from Jun. 2022 (€6.33 Mil) to Dec. 2022 (€4.92 Mil) and declined from Dec. 2022 (€4.92 Mil) to Jun. 2023 (€0.00 Mil).

CStone Pharmaceuticals's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€1.84 Mil) to Dec. 2022 (€4.92 Mil) but then declined from Dec. 2022 (€4.92 Mil) to Dec. 2023 (€4.28 Mil).

CStone Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for CStone Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Short-Term Capital Lease Obligation Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.56

1.09

1.84

4.92

4.28

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial									1.84	6.33	4.92	-	4.28

CStone Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

CStone Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (STU:PH4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (STU:PH4) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

CSPHF:USA 02616:Hong Kong

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

CStone Pharmaceuticals (STU:PH4) Headlines

No Headlines